Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Anis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Myocarditis associated with COVID-19 vaccination
Alessandra Buoninfante, Arno C. Andeweg, Georgy Genov, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M. Leal, Adrian Simpson, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2360-2375
Open Access | Times Cited: 27
Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice
Emil Brociek, Agata Tymińska, Andrea Silvio Giordani, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 874-874
Open Access | Times Cited: 24
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
The mRNA-LNP vaccines – the good, the bad and the ugly?
Botond Z. Igyártó, Zhen Qin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Sex-specific differences in systemic immune responses in MIS-C children
Anuradha Rajamanickam, Nathella Pavan Kumar, Aishwarya Venkataraman, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Hypermethylation leads to the loss of HOXA5, resulting in JAG1 expression and NOTCH signaling contributing to kidney fibrosis
Xiao Xiao, Wei Wang, Chunyuan Guo, et al.
Kidney International (2024) Vol. 106, Iss. 1, pp. 98-114
Open Access | Times Cited: 6
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data
Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
Amir Munir, Alan Gutierrez, Juan Qin, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 540-553
Closed Access | Times Cited: 5
Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults
Yoshikazu Honda‐Okubo, Dimitar Sajkov, Bruce A. Wauchope, et al.
Vaccine (2025) Vol. 49, pp. 126744-126744
Closed Access
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis
Yuhsin Vivian Huang, Yin Sun, Harrison Chou, et al.
Circulation Research (2025)
Closed Access
The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis
Hing Wai Tsang, Gilbert T. Chua, Keith T. S. Tung, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination
Henrike Maatz, Eric L. Lindberg, Eleonora Adami, et al.
Nature Cardiovascular Research (2025)
Open Access
Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae
N Panagiotides, Michael Poledniczek, Martin Andreas, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 4
A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis
Yuhsin Vivian Huang, Daniel Lee, Yin Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Killing Small Businesses – A Covid Case Study
Biff Baker
Journal of Leadership Accountability and Ethics (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies
Sebastian Reinig, Shin‐Ru Shih
Biomedical Journal (2023) Vol. 47, Iss. 1, pp. 100666-100666
Open Access | Times Cited: 8
Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination
Enrico Ammirati, Nicolina Conti, Matteo Palazzini, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 3, pp. 97-112
Closed Access | Times Cited: 2
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
The Observed T Cell Receptor Space database enables paired-chain repertoire mining, coherence analysis, and language modeling
Matthew I. J. Raybould, Alexander Greenshields‐Watson, Parth Agarwal, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114704-114704
Open Access | Times Cited: 2
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants
Qihong Yan, Xijie Gao, Banghui Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children
Donato Amodio, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
Clinical Immunology (2023) Vol. 255, pp. 109751-109751
Open Access | Times Cited: 7
Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males – Case reports
Donato Amodio, Emma Concetta Manno, Nicola Cotugno, et al.
Vaccine X (2023) Vol. 14, pp. 100318-100318
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top